<DOC>
	<DOCNO>NCT00207064</DOCNO>
	<brief_summary>We want relate disturbance first-episode schizophrenic patient serotonin 5-HT2A receptor , brain structure , brain function , information processing psychopathology . Additionally , want examine influence 5-HT2A receptor blockade disturbance . We expect disturbance serotonergic system baseline correlate specific structural functional change disruption information processing measure psychophysiological neurocognitive method - expect 5-HT2A receptor blockade reverse functional cognitive impairment . We expect effect treatment brain structure</brief_summary>
	<brief_title>Neurobiological Neurocognitive Disturbances First-episode Schizophrenia</brief_title>
	<detailed_description>Patients match healthy control examine baseline patient treat 6 month combine 5-HT2A- dopamine D2- receptor blocker . We choose atypical antipsychotic compound , quetiapine , present study since drug characterize fast koff/low affinity dopamine D2 receptor . The purpose study examine pathophysiological neuropsychological mechanism - treatment effect . We want characterize neurobiological functional endophenotypes vulnerability indicator study stability time relation treatment contemporary psychopathology . To extent candidate endophenotypes characterize stable independent treatment contemporary psychopathology analyse together similar finding previous ( identical ) cohorts schizophrenic patient . Specific disturbance also related candidate gene schizophrenia .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Firstepisode schizophrenia . The control match age , gender parental socioeconomic status Previous antipsychotic treatment , mental retardation , organic brain damage , control psychiatric diagnosis firstdegree relative psychiatric diagnosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>first-episode</keyword>
	<keyword>altanserin</keyword>
	<keyword>5-HT2A receptor</keyword>
	<keyword>MRI</keyword>
	<keyword>fMRI</keyword>
	<keyword>PPI</keyword>
	<keyword>P300</keyword>
	<keyword>P50 gating</keyword>
	<keyword>endophenotypes</keyword>
	<keyword>vulnerability indicator</keyword>
	<keyword>quetiapine</keyword>
</DOC>